Alzheimer Disease
1,723
322
401
832
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
240 trials with published results (14%)
Research Maturity
832 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.5%
112 terminated out of 1723 trials
88.1%
+1.6% vs benchmark
8%
145 trials in Phase 3/4
29%
240 of 832 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 832 completed trials
Clinical Trials (1723)
Decision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISION
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases
Study of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease
Safety and Efficacy of Plasma Transfusion From Exercise-trained Donors in Patients With Early Alzheimer's Disease
Clinical Trial on Agitation in Alzheimer's Dementia
Changing Talk Online Training (CHATO) National Trial
Detecting Beta-amyloid in the Retina
Neuroinflammation Imaging in AD
Improving PCP Advance Care Planning for People With ADRD
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Brain Energy for Amyloid Transformation in Alzheimer's Disease Study
Learning Skills Together Family Caregiver Complex Intervention
Cognitive Neurology Unit Clinical Registry
Fisetin in Mild Alzheimer's Disease
Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease (NIR4AD)
Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
rTMS for Apathy Clinical Trial
DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community